Forschung Unsere klinischen Studien

Studien

Altersbedingte Makuladegeneration

BLUE SKY Observational Study to Evaluate Fluid Resolution and Effectiveness in Patients Receiving Beovu in Neovascular Age-related Macular Degeneration

Nummer:
NCT04543331
Sponsor:
Novartis

Mylight Phase III Study Assessing the Efficacy, Safety and Immunogenicity of SOK583A1 Versus Eylea® in Patients With Neovascular Age-related Macular Degeneration (Mylight)

Nummer:
NCT04864834
Sponsor:
Sandoz/Hexal

RAZORBILL A Non-interventional Study to Assess the Influence of Automated Optical Coherence Tomography Image Enrichment With Segmentation Information on Disease Activity Assessment in Patients Treated With Licensed Anti-VEGF Injections

Nummer:
NCT04662944
Sponsor:
Novartis

Geographische Atrophie

ALXN2040-GA-201 Proof of Concept and Dose-finding Study of Danicopan in Patients With Geographic Atrophy Secondary to AMD

Sponsor:
Alexion Pharmaceuticals

EXPLORE A Phase 2, Outcomes Assessor-masked, Multicentre, Randomised Study to Evaluate the Safety and Efficacy of Two Doses of GT005 Administered as a Single Subretinal Injection in Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration

Nummer:
NCT04437368
Sponsor:
Gyroscope Therapeutics

HORIZON A Phase 2 Study to Evaluate the Safety and Efficacy of Two Doses of GT005

Nummer:
NCT04566445
Sponsor:
Gyroscope Therapeutics

Diabetisches Makulaödem

CT-P42 Study to Compare Efficacy and Safety of CT-P42 in Comparison With Eylea in Patients With Diabetic Macular Edema

Nummer:
NCT04739306
Sponsor:
Celltrion

KALAHARI A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema

Nummer:
NCT04527107
Sponsor:
Oxurion

LKA651 Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema

Nummer:
NCT03927690
Sponsor:
Novartis

PBM Beobachtungsstudie zu Wirksamkeit von Photobiomodulation durch Valeda Light System bei diabetischem Makulaödem.

Diabetische Retinopathie

NEON-NPDR Non-proliferative Diabetic Retinopathy Treated With Runcaciguat

Nummer:
NCT04722991
Sponsor:
Bayer

Makulaödem bei retinalen Venenverschlüssen

COMINO A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion

Nummer:
NCT04740931
Sponsor:
Hoffmann-La Roche

CoRaLa II Long-term need of Ranibizumab Injections With or Without Early Targeted Peripheral Laser Photocoagulation for Treatment of Macular Edema Due to Central Retinal Vein Occlusion

Nummer:
NCT04444492
Sponsor:
University of Leipzig

Premiumlinsen

GEMT-101-DEEP Prospektive kontrollierte klinische Studie zur Sicherheit und Wirksamkeit der HOYA Surgical Optics VIVINEX®GEMETRIC™ vorgeladenen Intraokularlinse

Nummer:
DRKS00015270
Sponsor:
Hoya

GEMT-102-NINO Klinische Studie zur Beurteilung der multifokalen vorgeladenen HOYA VIVINEX®GEMETRIC™ Intraokularlinsen nach Einführung in den Markt

Nummer:
DRKS00024535
Sponsor:
Hoya Surgical Optics GmbH

Myopietherapie

Atropin-Zulassung Dosisevaluierung von Atropin-Augentropfen zur Hemmung der Myopieprogression

Sponsor:
Pharma Stulln

Reti-Atro III Studie zur Untersuchung der Atropin-Dynamik im Auge nach topikaler Applikation